Avastin® (bevacizumab) Non-oncology

Avastin (bevacizumab) is covered for non‑oncology compendial off‑label neovascular/vascular ophthalmic conditions (e.g., diabetic macular edema/retinopathy, RVO‑related macular edema, myopic choroidal neovascularization, neovascular AMD, and other ocular neovascular diseases); oncology indications are excluded. Coverage requires documented diagnosis of an approved off‑label compendial use, meeting specific coverage and safety criteria, administration by or under an ophthalmologist’s supervision, and is authorized for up to 12 months.

"When requesting Avastin (bevacizumab) for non-oncology uses, the individual requiring treatment must be diagnosed with an approved off-label compendial use and meet the specific coverage guidelines..."

Sign up to see full coverage criteria, indications, and limitations.